These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17409273)

  • 21. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
    N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium.
    Münch G; Bölck B; Karczewski P; Schwinger RH
    J Mol Cell Cardiol; 2002 Mar; 34(3):321-34. PubMed ID: 11945024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
    Qvigstad E; Sjaastad I; Bøkenes J; Schiander I; Solberg L; Sejersted OM; Osnes JB; Skomedal T
    Eur J Pharmacol; 2005 May; 516(1):51-9. PubMed ID: 15916756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure.
    Bartholomeu JB; Vanzelli AS; Rolim NP; Ferreira JC; Bechara LR; Tanaka LY; Rosa KT; Alves MM; Medeiros A; Mattos KC; Coelho MA; Irigoyen MC; Krieger EM; Krieger JE; Negrão CE; Ramires PR; Guatimosim S; Brum PC
    J Mol Cell Cardiol; 2008 Aug; 45(2):240-9. PubMed ID: 18632114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta-blockers on free radical-induced cardiac contractile dysfunction.
    Flesch M; Maack C; Cremers B; Bäumer AT; Südkamp M; Böhm M
    Circulation; 1999 Jul; 100(4):346-53. PubMed ID: 10421593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered phosphorylation and calcium sensitivity of cardiac myofibrillar proteins during sepsis.
    Wu LL; Tang C; Liu MS
    Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R408-16. PubMed ID: 11448842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of beta-blocker therapy on high sensitivity c-reactive protein, oxidative stress, and cardiac function in patients with congestive heart failure.
    Nagatomo Y; Yoshikawa T; Kohno T; Yoshizawa A; Anzai T; Meguro T; Satoh T; Ogawa S
    J Card Fail; 2007 Jun; 13(5):365-71. PubMed ID: 17602983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes.
    Wang R; Miura T; Harada N; Kametani R; Shibuya M; Fukagawa Y; Kawamura S; Ikeda Y; Hara M; Matsuzaki M
    J Pharmacol Exp Ther; 2006 Jul; 318(1):45-52. PubMed ID: 16611853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.
    Flesch M; Ettelbrück S; Rosenkranz S; Maack C; Cremers B; Schlüter KD; Zolk O; Böhm M
    Cardiovasc Res; 2001 Feb; 49(2):371-80. PubMed ID: 11164847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation status of regulatory proteins and functional characteristics in myocardium of dilated cardiomyopathy of Syrian hamsters.
    Ohnuki Y; Nishimura S; Sugiura S; Saeki Y
    J Physiol Sci; 2008 Feb; 58(1):15-20. PubMed ID: 18177543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure.
    Ahmed A
    Eur J Heart Fail; 2003 Dec; 5(6):709-15. PubMed ID: 14675848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium.
    Molenaar P; Christ T; Berk E; Engel A; Gillette KT; Galindo-Tovar A; Ravens U; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):629-40. PubMed ID: 24668024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vagal heart rate responses to chronic beta-blockade in human heart failure relate to cardiac norepinephrine spillover.
    Kubo T; Parker JD; Azevedo ER; Atchison DJ; Newton GE; Picton P; Floras JS
    Eur J Heart Fail; 2005 Aug; 7(5):878-81. PubMed ID: 16087140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients.
    Bader FM; Hagan ME; Crompton JA; Gilbert EM
    J Heart Lung Transplant; 2005 Dec; 24(12):2144-7. PubMed ID: 16364863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
    Remme WJ; Torp-Pedersen C; Cleland JG; Poole-Wilson PA; Metra M; Komajda M; Swedberg K; Di Lenarda A; Spark P; Scherhag A; Moullet C; Lukas MA
    J Am Coll Cardiol; 2007 Mar; 49(9):963-71. PubMed ID: 17336720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carvedilol versus metoprolol in the acute phase of myocardial infarction:
    Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.